Endothelins

Their current status and future prospects

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Endothelins are potent peptide vasoconstrictors which were discovered two decades back. Their role in cardiovascular diseases, cancer, glaucoma, diabetes mellitus and many other diseases have been studied. Inspite of a lot of research many questions regarding their pathophysiological roles still remain unanswered. Though many endothelin receptor antagonists showed promising results in animal studies they failed to show significant improvement in clinical practice. The limitations of receptor antagonists lead to the research on synthesis inhibitors and their combinations with ACE inhibitors. This article summarizes the path of endothelins from their discovery to their current status and future prospects.

Original languageEnglish
Article number17
Pages (from-to)94-97
Number of pages4
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Volume23
Issue number2
Publication statusPublished - 23-12-2013

Fingerprint

Endothelins
Vasoconstrictor Agents
Research
Angiotensin-Converting Enzyme Inhibitors
Glaucoma
Diabetes Mellitus
Cardiovascular Diseases
Peptides
Neoplasms
Endothelin Receptor Antagonists

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{8110cb7952fc414ea7d87e1b5aff97a1,
title = "Endothelins: Their current status and future prospects",
abstract = "Endothelins are potent peptide vasoconstrictors which were discovered two decades back. Their role in cardiovascular diseases, cancer, glaucoma, diabetes mellitus and many other diseases have been studied. Inspite of a lot of research many questions regarding their pathophysiological roles still remain unanswered. Though many endothelin receptor antagonists showed promising results in animal studies they failed to show significant improvement in clinical practice. The limitations of receptor antagonists lead to the research on synthesis inhibitors and their combinations with ACE inhibitors. This article summarizes the path of endothelins from their discovery to their current status and future prospects.",
author = "Amrita Parida and Veena Nayak",
year = "2013",
month = "12",
day = "23",
language = "English",
volume = "23",
pages = "94--97",
journal = "International Journal of Pharmaceutical Sciences Review and Research",
issn = "0976-044X",
publisher = "Global Research Online",
number = "2",

}

Endothelins : Their current status and future prospects. / Parida, Amrita; Nayak, Veena.

In: International Journal of Pharmaceutical Sciences Review and Research, Vol. 23, No. 2, 17, 23.12.2013, p. 94-97.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Endothelins

T2 - Their current status and future prospects

AU - Parida, Amrita

AU - Nayak, Veena

PY - 2013/12/23

Y1 - 2013/12/23

N2 - Endothelins are potent peptide vasoconstrictors which were discovered two decades back. Their role in cardiovascular diseases, cancer, glaucoma, diabetes mellitus and many other diseases have been studied. Inspite of a lot of research many questions regarding their pathophysiological roles still remain unanswered. Though many endothelin receptor antagonists showed promising results in animal studies they failed to show significant improvement in clinical practice. The limitations of receptor antagonists lead to the research on synthesis inhibitors and their combinations with ACE inhibitors. This article summarizes the path of endothelins from their discovery to their current status and future prospects.

AB - Endothelins are potent peptide vasoconstrictors which were discovered two decades back. Their role in cardiovascular diseases, cancer, glaucoma, diabetes mellitus and many other diseases have been studied. Inspite of a lot of research many questions regarding their pathophysiological roles still remain unanswered. Though many endothelin receptor antagonists showed promising results in animal studies they failed to show significant improvement in clinical practice. The limitations of receptor antagonists lead to the research on synthesis inhibitors and their combinations with ACE inhibitors. This article summarizes the path of endothelins from their discovery to their current status and future prospects.

UR - http://www.scopus.com/inward/record.url?scp=84890453036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890453036&partnerID=8YFLogxK

M3 - Review article

VL - 23

SP - 94

EP - 97

JO - International Journal of Pharmaceutical Sciences Review and Research

JF - International Journal of Pharmaceutical Sciences Review and Research

SN - 0976-044X

IS - 2

M1 - 17

ER -